The leading developer of life sciences properties rode the industry’s wave last year, recording 4.1M SF of leases signed between October and December, more than double its best total for any quarter in Alexandria Real Estate Equities’ nearly 30-year history.
Its pace of activity is spurring the Pasadena, California-based real estate investment trust to venture into new territory — it is paying $402M for a nearly 1M SF life sciences campus in Texas, it disclosed in its quarterly earnings release this week.
Image: Courtesy of Alexandria Real Estate Equities Vaccine-maker Moderna inked one of the year’s biggest deals with Alexandria Real Estate Equities for a new Kendall Square headquarters.
{iframe}https://www.bisnow.com/national/news/life-sciences/alexandria-earnings-joel-marcus-111721{/iframe}